Determination of drugs in exhumed liver and brain tissue after over 9 years of burial by liquid chromatography-tandem mass spectrometry-Part 1: Cardiovascular drugs.


Journal

Drug testing and analysis
ISSN: 1942-7611
Titre abrégé: Drug Test Anal
Pays: England
ID NLM: 101483449

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 10 07 2020
revised: 17 09 2020
accepted: 25 09 2020
pubmed: 6 10 2020
medline: 29 10 2021
entrez: 5 10 2020
Statut: ppublish

Résumé

This paper should serve as support for future exhumations in which an analysis of cardiovascular drugs is issued after over 9 years of burial. Amiodarone, amlodipine, atropine, bisoprolol, cafedrine, clonidine, esmolol, furosemide, hydrochlorothiazide, lisinopril, nifedipine, nitrendipine, phenprocoumon, torsemide verapamil, and xipamide were determined in liver and brain tissue of over 100 cases in which exhumation was performed after over 9 years of burial. Diagrams, showing the detectability depending on postmortem period as well as condition of tissues, are presented for furosemide. This paper presents analytical results of cardiovascular drugs that were determined in exhumed liver and brain tissue in a total of 115 cases. Exhumations were executed after 9.5-16.5 years of burial. Analysis was performed by solid phase extraction and liquid chromatography-electrospray mass spectrometry. Bisoprolol, verapamil, and xipamide could be proven in all cases in which these were supposedly administered within a defined time frame. Amiodarone was detectable in over 90%, amlodipine in over 80%, and cafedrine, clonidine, phenprocoumon, and torsemide in over 50% of relevant cases. By contrast, atropine, esmolol, furosemide, hydrochlorothiazide, and lisinopril were found in less than 50% of relevant cases, but nifedipine and nitrendipine were not detectable at all. The percentage of positive results for liver and brain tissue for the relevant administered drugs and corresponding postmortem periods are presented per analyte. Neither time since death nor stage of degradation was a reliable predictor of the success rate, as exemplarily shown for furosemide. The presented data may serve as a reference when deciding whether to exhume a corpse for forensic-toxicological examinations in comparable cases.

Autres résumés

Type: Publisher (ger)
This paper presents analytical results of cardiovascular drugs that were determined in exhumed liver and brain tissue in a total of 115 cases. Exhumations were executed after 9.5-16.5 years of burial. Analysis was performed by solid phase extraction and liquid chromatography-electrospray mass spectrometry. Bisoprolol, verapamil, and xipamide could be proven in all cases in which these were supposedly administered within a defined time frame. Amiodarone was detectable in over 90%, amlodipine in over 80%, and cafedrine, clonidine, phenprocoumon, and torsemide in over 50% of relevant cases. By contrast, atropine, esmolol, furosemide, hydrochlorothiazide, and lisinopril were found in less than 50% of relevant cases, but nifedipine and nitrendipine were not detectable at all. The percentage of positive results for liver and brain tissue for the relevant administered drugs and corresponding postmortem periods are presented per analyte. Neither time since death nor stage of degradation was a reliable predictor of the success rate, as exemplarily shown for furosemide. The presented data may serve as a reference when deciding whether to exhume a corpse for forensic-toxicological examinations in comparable cases.

Identifiants

pubmed: 33017092
doi: 10.1002/dta.2940
doi:

Substances chimiques

Cardiovascular Agents 0

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

595-603

Informations de copyright

© 2020 John Wiley & Sons, Ltd.

Références

Tiess D. Asservierung, Exhumierung, Thanatochemie. In: Madea B, Brinkmann B(H, eds. Handbuch gerichtliche Medizin, Bd. 2. Berlin, Heidelberg, New York: Springer:70-88.
Grellner W, Glenewinkel F. Exhumations: synopsis of morphological and toxicological findings in relation to the postmortem interval. Survey on a 20-year period and review of the literature. Forensic Sci Int. 1997;90(1-2):139-159. https://doi.org/10.1016/s0379-0738(97)00154-0
Skopp G. Preanalytic aspects in postmortem toxicology. Forensic Sci Int. 2004;142(2-3):75-100. https://doi.org/10.1016/j.forsciint.2004.02.012
Käferstein H, Madea B, Sticht G, Sachs H. Toxicological findings after several years of burial. Acta Med Leg. 1994;44:439-442.
Karger B, de la Grandmaison GL, Bajanowski T, Brinkmann B. Analysis of 155 consecutive forensic exhumations with emphasis on undetected homicides. Int J Leg Med. 2004;118(2):90-94. https://doi.org/10.1007/s00414-003-0426-z
Ipsen B. Ueber den Nachweis von Atropin. Vjschr Gerichtl Med III. 1906;31:308-322.
Ikeda T, Tani N, Oritani S, Shida A, Aoki Y. Toxicological and biochemical analyses of an autopsy case involving oral overdose of multiple antidiabetic and antihypertensive drugs. Case Rep Med. 2018;2018:1-8. https://doi.org/10.1155/2018/5864658
Margalho C, de Boer D, Gallardo E, Barroso M, Vieira DN. Determination of furosemide in whole blood using SPE and GC-EI-MS. J Anal Toxicol. 2005;29(5):309-313. https://doi.org/10.1093/jat/29.5.309
Peters FT, Drummer OH, Musshoff F. Validation of new methods. Forensic Sci Int. 2007;165(2-3):216-224. https://doi.org/10.1016/j.forsciint.2006.05.021
Henning K, Teske J, Klintschar M, Dziadosz M. Postmortem findings of pipamperone after fatal intoxications and its distribution in body fluids and tissues. Drug Test Anal. 2019;11(4):626-630. https://doi.org/10.1002/dta.2574
Lüllmann H, Mohr K, Hein L. Pharmakologie und Toxikologie. Auflage ed. 17 Stuttgart, New York: Thieme:44.
Wagner JG. Some possible errors in the plotting and interpretation of semilogarithmic plots of blood level and urinary excretion data. J Pharm Sci. 1963;52(11):1097-1101.
Skopp G. Postmortem toxicology. Forensic Sci Med Pathol. 2010;6(4):314-325. https://doi.org/10.1007/s12024-010-9150-4
Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6-14. https://doi.org/10.1046/j.1365-2125.2003.02007.x
Baselt RC. Disposition of toxic drugs and chemicals in man. Tenth ed. Seal Beach: Biomedical Publications.
Favreto WAJ, Pugens Pinto AM, Manfio JL, Fiametti KG, Percio MF, Santos MBD. Development and validation of a UPLC-ESIMS/MS method for the determination of N-butylscopolamine in human plasma: application to a bioequivalence study. Drug Test Anal. 2012;4(3-4):215-221. https://doi.org/10.1002/dta.403
Ruß A, Endres S. Arzneimittelpocket plus. Auflage ed. 15 Grünwald: Börm Bruckmeier Verlag:56.
Krause D. Späte Leichenveränderungen. In: Madea B, Brinkmann B(H, eds. Handbuch gerichtliche Medizin, Bd. 1. Berlin, Heidelberg, New York: Springer:150.
Berg S. Leichenzersetzung und Leichenzerstörung. In: Mueller B, ed. Gerichtliche Medizin, Bd. 1. Berlin, Heidelberg, New York: Springer:62-106.
Baranda AB, Alonso RM, Jiménez RM, Weinmann W. Instability of calcium channel antagonists during sample preparation for LC-MS-MS analysis of serum samples. Forensic Sci Int. 2006;156(1):23-34. https://doi.org/10.1016/j.forsciint.2004.11.014
Wyman JF, Dean DE, Yinger R, et al. The temporal fate of drugs in decomposing porcine tissue. J Forensic Sci. 2011;56(3):694-699. https://doi.org/10.1111/j.1556-4029.2011.01725.x
Holmgren P, Druid H, Holmgren A, Ahlner J. Stability of drugs in stored postmortem femoral blood and vitreous humor. J Forensic Sci. 2004;49(4):820-825.
Brien JF, Jimmo S, Brennan FJ, Ford SE, Armstrong PW. Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues. Can J Physiol Pharmacol. 1987;65(3):360-364. https://doi.org/10.1139/y87-062
Stevens HM. The stability of some drugs and poisons in putrefying human liver tissues. J Forensic Sci Soc. 1984;24(6):577-589. https://doi.org/10.1016/s0015-7368(84)72350-4
Karger B. Exhumierungen. In: Madea B, Brinkmann B, eds. Handbuch gerichtliche Medizin, Bd. 1. Berlin, Heidelberg, New York: Springer:72-78.

Auteurs

Katarina Bolte (K)

Hannover Medical School, Institute for Forensic Medicine, Hannover, Niedersachsen, Germany.

Marek Dziadosz (M)

Hannover Medical School, Institute for Forensic Medicine, Hannover, Niedersachsen, Germany.

Naomi Kono (N)

Hannover Medical School, Institute for Forensic Medicine, Hannover, Niedersachsen, Germany.

Benedikt Vennemann (B)

Hannover Medical School, Institute for Forensic Medicine, Oldenburg, Niedersachsen, Germany.

Michael Klintschar (M)

Hannover Medical School, Institute for Forensic Medicine, Hannover, Niedersachsen, Germany.

Jörg Teske (J)

Hannover Medical School, Institute for Forensic Medicine, Hannover, Niedersachsen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH